International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10517140
Original Article
Evaluating the Effectiveness of the Ankle-Brachial Pressure Index as a Diagnostic Tool for Peripheral Arterial Disease in Patients with Diabetes Mellitus
 ,
 ,
 ,
Published
Jan. 16, 2024
Abstract

Background: Peripheral Arterial Disease (PAD) is a significant complication in patients with diabetes mellitus, often leading to increased morbidity. This study aimed to evaluate the effectiveness of the Ankle-Brachial Pressure Index (ABPI) as a diagnostic tool for PAD in this patient population.

Methods: This prospective study included 150 diabetic patients. The ABPI was measured and correlated with clinical parameters, including age, duration of diabetes, BMI, smoking status, and glycemic control. The sensitivity, specificity, and AUC of ABPI for PAD detection were calculated.

Results: The study found that abnormal ABPI readings were significantly associated with older age (p < 0.001), longer duration of diabetes (p < 0.001), higher BMI (p < 0.001), and smoking (p = 0.012). Poor glycemic control was also linked to abnormal ABPI readings (p < 0.001). The ABPI showed a sensitivity of 85% and a specificity of 80% for diagnosing PAD, with an AUC of 0.83. Patients with hypertension and dyslipidemia had a higher prevalence of abnormal ABPI readings.

Conclusion: ABPI is a reliable diagnostic tool for detecting PAD in patients with Diabetes Mellitus. Its effectiveness is influenced by several patient-related factors, including the duration of diabetes, BMI, and glycemic control. Regular ABPI screening is recommended in diabetic patients, especially those with additional cardiovascular risk factors.

 

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
1121 Views
328 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved